<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">354109</id>
  <title nil="true"/>
  <common-name>2-[2-[2-chloro-3-[2-(3,3-dimethyl-1-propylindol-1-ium-2-yl)ethenyl]cyclohex-2-en-1-ylidene]ethylidene]-3,3-dimethyl-1-propylindole</common-name>
  <description>2-[2-[2-chloro-3-[2-(3,3-dimethyl-1-propylindol-1-ium-2-yl)ethenyl]cyclohex-2-en-1-ylidene]ethylidene]-3,3-dimethyl-1-propylindole has the chemical formula C36H44ClN2+. With an average molecular weight of 540.20 g/mol, 2-[2-[2-chloro-3-[2-(3,3-dimethyl-1-propylindol-1-ium-2-yl)ethenyl]cyclohex-2-en-1-ylidene]ethylidene]-3,3-dimethyl-1-propylindole is a heavy molecule.</description>
  <cas nil="true"/>
  <pubchem-id>4345172</pubchem-id>
  <chemical-formula>C36H44ClN2+</chemical-formula>
  <weight>540.2</weight>
  <appearance nil="true"/>
  <melting-point nil="true"/>
  <boiling-point nil="true"/>
  <density nil="true"/>
  <solubility nil="true"/>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure nil="true"/>
  <target nil="true"/>
  <mechanism-of-toxicity nil="true"/>
  <metabolism nil="true"/>
  <toxicity nil="true"/>
  <lethaldose nil="true"/>
  <carcinogenicity nil="true"/>
  <use-source nil="true"/>
  <min-risk-level nil="true"/>
  <health-effects nil="true"/>
  <symptoms nil="true"/>
  <treatment nil="true"/>
  <created-at type="dateTime">2026-08-31T21:26:11Z</created-at>
  <updated-at type="dateTime">2026-08-31T21:26:11Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia nil="true"/>
  <uniprot-id nil="true"/>
  <kegg-compound-id nil="true"/>
  <omim-id nil="true"/>
  <chebi-id nil="true"/>
  <biocyc-id nil="true"/>
  <ctd-id nil="true"/>
  <stitch-id nil="true"/>
  <drugbank-id nil="true"/>
  <pdb-id nil="true"/>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>CCCN1C2=CC=CC=C2C(C1=CC=C3CCCC(=C3Cl)C=CC4=[N+](C5=CC=CC=C5C4(C)C)CCC)(C)C</moldb-smiles>
  <moldb-formula>C36H44ClN2+</moldb-formula>
  <moldb-inchi>InChI=1S/C36H44ClN2/c1-7-24-38-30-18-11-9-16-28(30)35(3,4)32(38)22-20-26-14-13-15-27(34(26)37)21-23-33-36(5,6)29-17-10-12-19-31(29)39(33)25-8-2/h9-12,16-23H,7-8,13-15,24-25H2,1-6H3/q+1</moldb-inchi>
  <moldb-inchikey>MMSREVPDKSWDLN-UHFFFAOYSA-N</moldb-inchikey>
  <moldb-average-mass type="decimal" nil="true"/>
  <moldb-mono-mass type="decimal">539.3193021</moldb-mono-mass>
  <origin nil="true"/>
  <state nil="true"/>
  <logp>9.2</logp>
  <hmdb-id nil="true"/>
  <chembl-id nil="true"/>
  <chemspider-id nil="true"/>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference nil="true"/>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM350002</chemdb-id>
  <dsstox-id nil="true"/>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id nil="true"/>
  <iupac>2-[2-[2-chloro-3-[2-(3,3-dimethyl-1-propylindol-1-ium-2-yl)ethenyl]cyclohex-2-en-1-ylidene]ethylidene]-3,3-dimethyl-1-propylindole</iupac>
  <moldb-polar-surface-area nil="true"/>
  <moldb-refractivity nil="true"/>
  <moldb-polarizability nil="true"/>
  <moldb-rotatable-bond-count nil="true"/>
  <moldb-acceptor-count nil="true"/>
  <moldb-donor-count nil="true"/>
  <moldb-pka-strongest-acidic nil="true"/>
  <moldb-pka-strongest-basic nil="true"/>
  <moldb-physiological-charge nil="true"/>
  <moldb-number-of-rings nil="true"/>
  <moldb-alogps-logp nil="true"/>
  <moldb-alogps-logs nil="true"/>
  <moldb-alogps-solubility nil="true"/>
  <kingdom>Organic compounds</kingdom>
  <superklass>Organoheterocyclic compounds</superklass>
  <klass>Indoles and derivatives</klass>
  <subklass>Indoles</subklass>
  <paper-count type="integer" nil="true"/>
  <sync-id>CED0304391</sync-id>
  <structure-inchikey>MMSREVPDKSWDLN-UHFFFAOYSA-N</structure-inchikey>
  <structure-fingerprint>109000000000000800000000000000000002000000000000000000000000000004202000000000000000000040000100000000000000001000000000000000000000000408000080000000004000000000000000200000001000000000000000020000808001000000000000028040001020100000000000000000004000800080848000000800100000000004000000000000100000000000000000021000100000000000000048000080000000000108000000800000000000000000000000000000820000008000000010000000010000040000000200200000000002000000008000000000040000000000010000000100000080000000000000000</structure-fingerprint>
  <structure-pattern-fingerprint>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</structure-pattern-fingerprint>
  <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAnAAAAKwAAAIABBgBgAAAAAQMGAGAAAAAC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</structure-pickle>
  <structure-indexed-at type="dateTime">2026-09-19T05:51:58Z</structure-indexed-at>
</compound>
